Stockscreener 앱 받기
0.8133
2.19%
0.0174
시장 영업 전:
.82
0.0067
+0.82%
Hyperfine Inc 주식(HYPR)의 최신 뉴스
Hyperfine stock reports 45 percent revenue growth - AD HOC NEWS
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026Slideshow (NASDAQ:HYPR) 2026-06-05 - Seeking Alpha
BTIG reiterates Hyperfine stock rating on commercial progress By Investing.com - Investing.com Nigeria
HYPR Reiterated by BTIG -- Price Target Maintained at $2.00 - GuruFocus
BTIG reiterates Hyperfine stock rating on commercial progress - Investing.com
BTIG reiterates Buy rating on Hyperfine, $2 price target - TradingView
Hyperfine Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Hyperfine stock holds steady as investors await fresh signals - AD HOC NEWS
Hyperfine completes enrolment in contrast-enhanced Swoop MRI Study - Indian Pharma Post
Hyperfine CEO Maria Sainz Wins 2026 MedtechWOMEN Leadership Award - citybiz
MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award - Business Wire
Hyperfine completes enrollment in contrast MRI study By Investing.com - Investing.com Australia
Hyperfine completes enrollment in contrast MRI study - Investing.com
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents - Business Wire
Hyperfine stock maintains buy rating at BTIG on AI software update - Investing.com Canada
Lioness Medtech Showcasing Hyperfine Swoop at Röntgenveckan 2026 - marketscreener.com
HYPR Q2 2026 Earnings: EPS Loss of -$0.09 Narrowly Beats Estimates, Stock Slips 1.4%Profit Recovery Report - dars.gov.et
HYPR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Hyperfine (HYPR) Holds at $0.81, Pressing Against Support After Mild PullbackMarket Neutral Pair - siam.in
Hyperfine Forms Global Neurosurgery Advisory Council - Medical Product Outsourcing
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference - Yahoo Finance
Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Nigeria
Hyperfine reports 3,000 scans completed in first office year - Investing.com
Hyperfine (HYPR) Earnings Update: The Available Earnings Metric Delivers a Beat at the Close; Market Response: Shares Finish 4.21% Down for the Current SessionEnergy Earnings Report - vinanet.vn
HYPR | Hyperfine, Inc. Class A FinancialsRevenue Breakdown - Quiver Quantitative
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - AOL.com
BTIG reiterates Hyperfine stock rating on FDA software clearance By Investing.com - Investing.com Canada
BTIG reiterates Hyperfine stock rating on FDA software clearance - Investing.com
Hyperfine Wins FDA Clearance for Next Optive AI Software - Medical Product Outsourcing
Hyperfine receives FDA clearance for Swoop MRI software update - Investing.com
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com South Africa
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings - Business Wire
Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerEarnings Momentum Score - vinanet.vn
HYPR Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares SlipEarnings Stability Report - vinanet.vn
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeLiquidity Order Flow - vinanet.vn
Hyperfine, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-08-10 - Seeking Alpha
HYPR Reiterates by B. Riley Securities -- Price Target Lowers to $1.60 - GuruFocus
B. Riley Financial Reaffirms Buy Rating for Hyperfine (NASDAQ:HYPR) - MarketBeat
HYPR Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 2.83%EPS Surprise History - dars.gov.et
Hyperfine Q2 2026 slides: 45% revenue growth, AI-powered MRI expansion - Investing.com Australia
Hyperfine Inc (HYPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hyperfine Touts Positive Results From Portable MRI Study - Medical Product Outsourcing
Hyperfine, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results - MarketBeat
Hyperfine Q2 Earnings Call Highlights - MarketBeat
1.51%
0.97%
자본화:
|
볼륨(24시간):